Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanping Liang

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Clinical and Translational Medicine|July 27, 2023
Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinomaJunjie Cen, Yanping Liang, Zihao Feng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 PathwaysJinchen Luo, Hansen Lin, Haoqian Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2022
Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancerLingling Duan, Yu-An Chen, Yanping Liang, et al.
Nucleic Acids Research|October 25, 2019
Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivationLingling Duan, Zhenhua Chen, Jun Lu, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Clinical and Translational Medicine|July 27, 2023
Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinomaJunjie Cen, Yanping Liang, Zihao Feng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 PathwaysJinchen Luo, Hansen Lin, Haoqian Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2022
Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancerLingling Duan, Yu-An Chen, Yanping Liang, et al.
Nucleic Acids Research|October 25, 2019
Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivationLingling Duan, Zhenhua Chen, Jun Lu, et al.
Pageof 8